Key facts
- This page summarizes Diane Jorkasky's Form 4 filing for Altimmune, Inc. (ALT).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 29 Dec 2025, 16:10.
Diane Jorkasky - 29 Dec 2025 Form 4 Insider Report for Altimmune, Inc. (ALT)
- Reporting relationship
- Director
- Issuer ticker
- ALT
- Reported as of
- 29 Dec 2025
- Net transaction value
- +$2,003
- SEC form
- 4
- Accepted by SEC
- 29 Dec 2025, 16:10:05 UTC
- Prior SEC filing
- 29 Sep 2025
- Next SEC filing
- 01 May 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Gregory Weaver, as Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Filing notes and source
Key filing fact
Diane Jorkasky filed Form 4 for Altimmune, Inc. (ALT) on 29 Dec 2025.
Change
- Previous filing in this sequence was filed on 29 Sep 2025.
- Current net transaction value: +$2,003.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001527204
Primary reporting owner
Jorkasky Diane
- Relationship
- Director
- Address
- 910 CLOPPER ROAD, SUITE 201S, GAITHERSBURG
- Signature
- /s/ Gregory Weaver, as Attorney-in-Fact
- Signature date
- 29 Dec 2025
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ALT
transaction
Common Stock, par value $0.0001
Purchase
- Transaction value
- $2,003
- Shares
- +527
- Change %
- Price
- $3.80
- Shares after
- 527
- Date
- 29 Dec 2025
- Ownership
- Direct
* marks a reported price that did not pass the local price check.